# Dietary Fructose on Microbiota and Hepatosteatosis

> **NCT04898621** · NA · COMPLETED · sponsor: **Shanghai Zhongshan Hospital** · enrollment: 58 (actual)

## Conditions studied

- Hepatic Steatosis
- Dietary Fructose Exposure

## Interventions

- **DIETARY_SUPPLEMENT:** 75g fructose solution
- **DIETARY_SUPPLEMENT:** 150g fructose solution

## Key facts

- **NCT ID:** NCT04898621
- **Lead sponsor:** Shanghai Zhongshan Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-01
- **Primary completion:** 2022-08-31
- **Final completion:** 2022-12-31
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2023-06-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898621

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898621, "Dietary Fructose on Microbiota and Hepatosteatosis". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04898621. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*